A retrospective analysis to estimate the healthcare resource utilization and cost associated with treatment-resistant depression in commercially insured US patients.

Gang LiLing ZhangAllitia DiBernardoGrace WangJohn J SheehanKwan LeeJohan ReutforsQiaoyi Zhang

Published in: PloS one (2020)

Treatment-resistant depression was associated with higher healthcare resource utilization and costs versus non-treatment-resistant major depressive disorder in this commercially insured cohort of patients in the United States.

Keyphrases

healthcare
major depressive disorder
end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
peritoneal dialysis
bipolar disorder
depressive symptoms
prognostic factors
patient reported outcomes
social media